Brief: FDA Approves Astellas' Vyloy For A Type Of Gastroesophageal Junction Adenocarcinoma
18/10/2024 17:23
Oct 18 (Reuters) - FDA
* FDA APPROVES ASTELLAS'S VYLOY- WEBSITE
* FDA: APPROVES ASTELLAS' VYLOY FOR A TYPE OF
GASTROESOPHAGEAL
JUNCTION ADENOCARCINOMA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astellas Pharma
See all newsBrief: Immuneering To Collaborate With Astellas On Clinical Studies Of Investigational CLDN18.2 Programs In Combination With Atebimetinib For Pancreatic Cancer Patients
Health Rounds: New blood test finds early risk for ovarian cancer
Health Rounds: New blood test finds early risk for ovarian cancer
Refile: Astellas employee imprisoned in China to be released in December, Japanese media report
Table: Astellas Pharma -6-MTH group results (IFRS)